Dokter PET/CT tetap digunakan sebagai istilah dalam konteks medis di Indonesia di Luar Negeri — Halaman 4

Dokter adalah seorang ahli onkologi medis dan internis Austria yang terkemuka dengan pengalaman lebih dari dua dekade, yang berspesialisasi dalam kanker payudara, keganasan ginekologi, dan terapi kanker yang ditargetkan. Lulusan Universitas Wina, dokter menyelesaikan residensi dalam bidang penyakit dalam dan onkologi medis di Universitas Kedokteran Wina. Dokter telah berkontribusi pada uji klinis awal tentang terapi yang ditargetkan dan merupakan otoritas terkemuka dalam pengobatan kanker yang dipersonalisasi.<\/p>

Saat ini menjabat sebagai konsultan senior di Wiener Privatklinik dan melanjutkan pekerjaan akademis di Universitas Kedokteran Wina, dokter berfokus pada terapi kanker sistemik yang dipersonalisasi, imunoterapi, dan penelitian kanker translasi. Penelitian dokter mencakup pengembangan biomarker dan mekanisme resistensi terhadap obat yang ditargetkan, dengan publikasi di jurnal internasional terkemuka.<\/p>

Dokter adalah seorang ahli onkologi radiasi yang sangat terampil dengan pengalaman luas dalam merawat berbagai jenis kanker menggunakan teknik terapi radiasi canggih. Mereka memiliki rekam jejak yang terbukti dalam meningkatkan hasil pasien melalui rencana perawatan yang dipersonalisasi dan teknologi mutakhir.<\/p>

Bersertifikat dalam onkologi radiasi, dokter telah berkontribusi pada banyak uji klinis dan studi penelitian, meningkatkan pemahaman dan efektivitas perawatan radiasi. Mereka berkomitmen untuk pembelajaran berkelanjutan dan telah menghadiri berbagai konferensi internasional untuk tetap mengikuti perkembangan terbaru di bidang ini.<\/p>

Dr. Viola Fox adalah Kepala Dokter di Klinik Hematologi, Onkologi, dan Kedokteran Paliatif di BKZ Solingen. Klinik ini merupakan pusat kanker interdisipliner yang telah tersertifikasi. Dr. Fox adalah pakar terkemuka dalam terapi obat untuk penyakit tumor di Jerman dan Eropa. Dia memiliki lebih dari 15 tahun pengalaman di bidang ini.

Dia adalah anggota dari German Society of Oncology and Haemato-oncology (GDHO), German Association of Physicians, dan American Association for Cancer Research. Dr. Fox juga aktif dalam penelitian biologi molekuler. Karyanya mendukung kemajuan dalam pengobatan kanker dan diagnostik molekuler.

Bidang keahliannya meliputi kemoterapi, imunoterapi, terapi target, dan terapi radiasi. Dr. Fox dikenal karena metode-metodenya yang inovatif dan komitmen kuatnya terhadap perawatan pasien. Usahanya telah menghasilkan tingkat pemulihan yang tinggi dan pengakuan dari rekan-rekannya.

Dokter adalah seorang ahli onkologi yang berspesialisasi dalam pengobatan kanker payudara, paru-paru, dan saluran pencernaan. Saat ini, dokter berpraktik di Rumah Sakit Universitas Istinye Liv.

Dengan karier yang mencakup berbagai institusi terkemuka, dokter telah bertugas sebagai Spesialis Penyakit Dalam di Rumah Sakit Negara Malatya, dokter di Klinik Onkologi Ankara, dan anggota Departemen Onkologi di Rumah Sakit Pelatihan dan Penelitian Regional Erzurum.

Dokter lulus dari Fakultas Kedokteran Universitas Selcuk dan meraih gelar Associate Professor pada tahun 2016.

Dokter lulus dengan pujian pada tahun 2004 dari Julius-Maximilians-Universität Würzburg. Ia memulai karirnya di Hamburg, mendapatkan pengalaman dalam radiologi di Klinik Hamburg-Altona. Ia memperdalam keahliannya di Rumah Sakit Universitas Aachen, bekerja dengan para profesional terkenal dan menguasai teknik pencitraan modern seperti ultrasonografi, CT, dan MRI untuk intervensi kompleks.<\/p>

Pada tahun 2010, ia menjadi dokter utama Klinik Radiologi Diagnostik dan Intervensional, kemudian menjabat sebagai dokter utama di bawah Profesor Kuhl hingga 2022. Saat ini, ia adalah Dokter Kepala Klinik Radiologi Diagnostik dan Intervensional di Rumah Sakit Akademik Solingen.<\/p>

Spesialisasinya meliputi pencitraan penampang, radiologi intervensional, ultrasonografi, diagnostik sinar-X, dan diagnostik payudara.<\/p>

Dr. Cemil Bilir is a professor of medical oncology at VM Medical Park Pendik Hospital in Istanbul. He specializes in immunotherapy and chemotherapy for lung, breast, and prostate cancers. A former research fellow at Northeastern University in Boston, he focused on pharmaceutical biotechnology and nanomedicine. Dr. Bilir works at a JCI-accredited facility where academic physicians provide around-the-clock care.

• Member of the American Society of Clinical Oncology (ASCO) and ESMO.
• Completed a specialized clinical rotation at the Cleveland Clinic in the U.S.
• Treats complex oncological cases, including stage 4 lung cancer and sarcoma.
• Current Ph.D. student in inorganic chemistry at Sakarya University.

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Dr. Murat Atay is a breast and general surgeon at Istanbul Florence Nightingale Hospital. He completed specialized training in sentinel node mapping at the MDA Cancer Center in Texas. Dr. Atay also held several surgical roles at Lille University Hospital in France. He focuses on breast and thyroid surgery as well as oncological procedures.

• Performs mastectomy, lumpectomy, and lymphadenectomy.
• Treats conditions such as breast cancer and fibrocystic breast disease.
• Practices at a JCI-accredited smart hospital that treats 300,000 patients annually.
• Uses PET-MRI and mammography for precise diagnosis and monitoring.

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Dr. Gul Alco is a radiation oncologist and Professor at Medipol Acibadem District Hospital in Istanbul. She excels in treating complex cases, including stage 4 lung and liver cancers. Dr. Alco utilizes the CyberKnife and Da Vinci robotic systems for precise tumor targeting. She works at a JCI-accredited facility known for its high safety standards.

• Specializes in brachytherapy and high-intensity focused ultrasound ablation (HIFU).
• Performs radiofrequency ablation and proton-beam therapy for various malignancies.
• Treats pancreatic, breast, ovarian, and brain cancers using targeted radiation.
• Expert in nuclear medicine diagnostics, including PET-CT with Gallium 68.

Dr. Baha Zengel is a general surgeon at Medicalpoint International Hospital. He specializes in oncoplastic breast surgery and thyroid diseases. He holds a doctorate in Basic Oncology from Dokuz Eylül University. Dr. Zengel serves as a founding board member of the Basic Oncology Association. He works at a JCI-accredited facility in İzmir.

• Performs breast-conserving mastectomy and simultaneous reconstructions.
• Expert in ROLL and SNOLL localization techniques for non-palpable lesions.
• Treats patients using laparoscopic cholecystectomy for gallbladder diseases.
• Former board member of the Aegean Region Surgery Association.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Felix Dobritoiu is a thoracic surgeon at Ponderas Academic Hospital in Bucharest. He performs robotic thoracic surgery using the da Vinci Xi system. Dr. Dobritoiu treats both adults and children. He focuses on small-incision techniques to ensure faster patient recovery. His hospital holds JCI accreditation and acts as a Robotic Surgery Center of Excellence.

• Specializes in video-assisted thoracoscopic surgery (VATS) including uniportal techniques.
• Performs complex lung resections, mediastinoscopy, and bronchoscopy.
• Treats lung cancer, thymoma, thyroid cancer, and adenocarcinoma.
• Offers sternochondroplasty for chest wall deformities using the Nuss procedure.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. LV Xiao Jun is the Executive Director of the Department of Medical Oncology. He is a national expert in psycho-oncology and has 30 years of clinical experience. He previously served at the First Affiliated Hospital of Xiamen University. He is a recognized expert in cancer treatment and lung cancer care in Fujian Province.

Clinical focus: comprehensive care for solid tumors, including lung, breast, and gastrointestinal cancers; palliative care in oncology; and screening and treatment for psychological distress.

Appointments: Standing Committee Member (third term), Psycho-Oncology Committee, Chinese Anti-Cancer Association; Standing Committee Member (third term), Lung Cancer Committee, Fujian Anti-Cancer Association.

Dr. Yan Zhi Ping is the Director of the Radiology Department at Xiamen Humanity Hospital. He graduated from the First Military Medical University. He has authored more than 30 papers. He has edited and contributed to several monographs. He received a Fujian Provincial Third Prize for Science and Technology Progress and two Xiamen Municipal Second Prizes. His expertise includes CT and MRI of the central nervous system, musculoskeletal system, thoracic, and abdominal diseases. He also focuses on cerebral functional imaging. He is skilled in the early diagnosis and differential diagnosis of lung cancer and brain tumors.

Appointments: Standing Committee Member of the Radiology Branch of the Fujian Association of Integrative Medicine. Standing Committee Member of the Fujian Radiological Society. Vice Chairman of the Xiamen Radiological Society. Vice Chairman of the Radiology Branch of the Xiamen Medical Doctor Association. Deputy Director of the Xiamen Radiology Quality Control Center.